In a model validation, shortened sleep duration was predictable by daytime sleepiness (ESS), BMI and ASAT, whereas prolonged sleep duration was predictable by fasting insulin with differential effect for NAFLD patients vs. controls, respectively (S1 Table). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.